E
Eckhard Thiel
Researcher at Charité
Publications - 621
Citations - 32083
Eckhard Thiel is an academic researcher from Charité. The author has contributed to research in topics: Transplantation & Leukemia. The author has an hindex of 83, co-authored 621 publications receiving 30313 citations. Previous affiliations of Eckhard Thiel include Franklin University & Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht,David W. Denning,David W. Denning,Thomas F. Patterson,John E. Bennett,Reginald Greene,Reginald Greene,J. W. Oestmann,Winfried V. Kern,Winfried V. Kern,Winfried V. Kern,Kieren A. Marr,Patricia Ribaud,Olivier Lortholary,Richard J. Sylvester,Robert H. Rubin,John R. Wingard,Paul Stark,Christine Durand,Denis Caillot,Eckhard Thiel,Pranatharthi H. Chandrasekar,Michael R. Hodges,Haran T. Schlamm,Peter F. Troke,Ben E. De Pauw +25 more
TL;DR: In patients with invasive aspergillosis,Initial therapy with voriconazole led to better responses and improved survival and resulted in fewer severe side effects than the standard approach of initial therapy with amphotericin B.
Journal ArticleDOI
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Gero Hütter,Daniel Nowak,Maximilian Mossner,Susanne Ganepola,Kristina Allers,Thomas Schneider,Jörg Hofmann,Claudia Kücherer,Olga Blau,Igor Wolfgang Blau,Wolf K. Hofmann,Eckhard Thiel +11 more
TL;DR: Stem cells from a donor who was homozygous for CCR5 delta32 were transplanted in a patient with acute myeloid leukemia and HIV-1 infection and the patient remained without viral rebound 20 months after transplantation and discontinuation of antiretroviral therapy.
Journal ArticleDOI
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
David W. Denning,Patricia Ribaud,Noel Milpied,Denis Caillot,Raoul Herbrecht,Eckhard Thiel,Andrea Haas,Markus Ruhnke,Hartmut Lode +8 more
TL;DR: Voriconazole is efficacious in treating acute IA and is proven and probable in 68 patients, and good responses were seen in 60% of those with pulmonary or tracheobronchial IA and 26% of allogeneic stem cell transplant recipients.
Journal ArticleDOI
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma
Lauren E. Abrey,Tracy T. Batchelor,A. J. M. Ferreri,Mary Gospodarowicz,Elisa Jacobsen Pulczynski,Emanuele Zucca,Justine R. Smith,Agnieszka Korfel,Carole Soussain,Lisa M. DeAngelis,Edward A. Neuwelt,Brian P. O'Neill,Eckhard Thiel,Tamara Shenkier,Fransesc Graus,Martin J. van den Bent,John F. Seymour,Philip Poortmans,James O. Armitage,Franco Cavalli +19 more
TL;DR: An international group of experts meeting to review current standards of reporting and to formulate a consensus opinion regarding minimum baseline evaluation and common standards for assessing response to therapy hope that these guidelines will improve communication among investigators and comparability among clinical trials in a way that will allow to develop better therapies for patients.
Journal ArticleDOI
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.
Kristina Allers,Gero Hütter,Jörg Hofmann,Christoph Loddenkemper,Kathrin Rieger,Eckhard Thiel,Thomas Schneider +6 more
TL;DR: Successful reconstitution of CD4(+) T cells at the systemic level as well as in the gut mucosal immune system after CCR5Δ32/Δ 32 stem cell transplantation is demonstrated, suggesting that cure of HIV has been achieved in this patient.